Home > Insider Trading > Filing (0000914190-12-000240)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1133869	Nile Therapeutics Inc.	NLTX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189164	B Richard Brewer	C/O Nile Therapeutics, Inc. 4 West 4Th Avenue, Suite 400 San Mateo CA 94402	Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-03-30	125,000	$0.00	125,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (Right to Buy)	Acquisiton	2012-03-30	93,750	$0.00	93,750	$0.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
93,750			No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$0.32	2010-07-21	2020-07-21	450,000	450,000	Direct
Common Stock	Stock Option (Right to Buy)	$0.37		2020-07-26	900,000	900,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2020-07-21	450,000	450,000	Direct
2020-07-26	900,000	900,000	Direct

Footnotes

The reported securities were purchased by the Reporting Person at an aggregate price of $0.40 for one share of common stock and three-fourths of a warrant to purchase one share of common stock.
This option vests in eight equal quarterly installments beginning 9/30/2011.
The warrants are exercisable for a period of five years beginning on the earlier of (i) the date on which a registration statement under the Securities Act of 1933, as amended, covering the shares of common stock issuable upon exercise of the warrants and the subsequent resale of such shares is declared effective by the Securities and Exchange Commission, and (ii) one year and one day after issuance.